Medicare Compliance & Reimbursement - 2007 Issue 26
STUDIES & SURVEYS: Say Goodbye To Drug Reps -- And Gain An Extra $12,000
Subscribe or sign in to view the full article.
Article Overview
This article summarizes survey findings and commentary about physician time spent meeting with drug company representatives, how that time may affect practice scheduling, and the financial opportunity cost discussed in the context of outpatient office visits. It is aimed at physicians, practice managers, and coding/billing professionals who track workflow, revenue impact, and general utilization trends tied to ambulatory services and industry interaction. The piece also references broader study findings about drug samples and catered meals, but does not present detailed coding guidance.
Why This Topic Matters
It helps readers understand a workflow and revenue discussion around physician time allocation in outpatient practice and how that discussion is framed using a common evaluation and management service code.
What You Will Learn
- How physician time spent with pharmaceutical representatives is characterized in the article
- Why the article links practice time allocation to potential revenue impact
- What survey and study trends are mentioned regarding drug samples and catered meals
- How the article frames the issue for medical practices and physicians
Who Should Read This
- Physicians
- Medical practice managers
- Medical coders
- Billing staff
- Healthcare administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com